(19)

(11)

EP 4 739 348 A1

(12)

(43) Date of publication: 13.05.2026 Bulletin 2026/20 (21) Application number: 24739542.9 (22) Date of filing: 04.07.2024

(51) International Patent Classification (IPC):  A61K 47/69(2017.01) C12N 9/20(2006.01) C12N 11/14(2006.01) C12N 11/04(2006.01) C12N 9/96(2006.01) A61K 38/46(2006.01) (52) Cooperative Patent Classification (CPC): C12N 9/20; C12Y 301/01003; C12N 11/14; C12N 9/96; C12N 11/04; A61K 47/6923; A61K 47/6929 (86) International application number: PCT/EP2024/068816 (87) International publication number: WO 2025/008442 (09.01.2025 Gazette 2025/02)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 06.07.2023 EP 23183863 (71) Applicant: Perseo Pharma AG 4132 Muttenz (CH)	(72) Inventors: BRIAND, Manon 5408 Ennetbaden (CH) LAPRÉVOTTE, Emilie 68220 Hegenheim (FR) DUDAL, Yves Victor René 4103 Bottmingen (CH) SHAHGALDIAN, Patrick 68220 Hegenheim (FR) (74) Representative: Latscha Schöllhorn Partner AG  Grellingerstrasse 60 4052 Basel 4052 Basel (CH)